/Companies

CoLabs Int'l

Huntington Beach, US · Nevada corporation

Find your way into CoLabs Int'l

Sign up to see every warm intro you have to CoLabs Int'l

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the CoLabs Int'l team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

LC
Laura CohenNamed on SEC filing
LL
Lisa LeBlancNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$6.4M disclosed across 5 rounds · 2013–2023

▶$315KraisedJun 2023 · 4 investors · Other Health Care
Officers, directors & promoters on the filing
  • Peter Barton HuttDirector
  • Dean StathakisDirector
  • Charles FrittsDirector
  • Laura CohenExecutive Officer, Director, Promoter
  • Lisa LeBlancExecutive Officer, Director, Promoter
  • William CohenExecutive Officer, Promoter
  • Daniel TraynorExecutive Officer
Offering amount
$600K
Amount sold
$315K
Minimum investment
$15K
First sale
Feb 2023
Incorporated
Corporation, Nevada
Federal exemptions
04
Full filing on SEC EDGAR ↗
▶$165KraisedSep 2021 · 2 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • Daniel TratynorExecutive Officer
  • Dean StathakisDirector
  • Peter Barton-HuttDirector
  • Charles FrittsDirector
  • Gerald BirchExecutive Officer
  • Laura CohenExecutive Officer, Director, Promoter
  • William CohenPromoter
  • Lisa LeBlancExecutive Officer, Director, Promoter
Offering amount
$16.5M
Amount sold
$165K
Minimum investment
$50K
First sale
Aug 2021
Incorporated
Corporation, Nevada
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$540KraisedFeb 2021 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Dean StathakisDirector
  • Gerald BirchExecutive Officer
  • Charles FrittsDirector
  • Laura CohenExecutive Officer, Director, Promoter
  • Lisa LeBlancExecutive Officer, Director, Promoter
  • Peter Barton-HuttDirector
Offering amount
$540K
Amount sold
$540K
Minimum investment
$50K
First sale
Feb 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedFeb 2021 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Laura CohenExecutive Officer, Director, Promoter
  • Gerald BirchExecutive Officer
  • Charles FrittsDirector
  • Dean StathakisDirector
  • Peter Barton-HuttDirector
  • Lisa LeBlancExecutive Officer, Director, Promoter
Offering amount
$3M
Amount sold
$3M
Minimum investment
$20K
First sale
Jun 2013
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.4MraisedJan 2021 · 26 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Laura CohenExecutive Officer, Director, Promoter
  • Lisa LeBlancExecutive Officer, Director, Promoter
Offering amount
$2.4M
Amount sold
$2.4M
Minimum investment
$3K
First sale
Jan 2019
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has CoLabs Int'l raised?
CoLabs Int'l has disclosed $6.4M raised across 5 rounds.
Where is CoLabs Int'l headquartered?
CoLabs Int'l is headquartered in Huntington Beach, US.